Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD
NCT01269151
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Age-Related Macular Degeneration
Retinal Function
Interventions
DRUG:
Lucentis (Ranibizumab)
Sponsor
University of Luebeck